packageSebelipaseAlfa

sebelipase alfa

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Sebelipase alfa, a recombinant form of the enzyme lysosomal acid lipase, is used to treat lysosomal acid lipase deficiency, an inborn error of lipid metabolism. It is an approved enzyme medication authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q21789862 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:sebelipase alfa
ATC codes:A16AB14
DrugBank:DB11563
Wikidata:Q21789862
molar mass:55000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown